Boehringer Ingelheim Roxane Inc voluntarily recalled Spiriva HandiHaler capsules nationwide and in Puerto Rico on March 27, 2014, according to the FDA. The recall addresses a defective delivery system that may cause dose delivery out of specification. The firm initiated this Class III recall.
How to tell if you have it
- Brand: Spiriva
- Product: Spiriva HandiHaler Capsules (tiotropium bromide inhalation powder)
- NDC 0597-0075-75, 5 count blister card, Lot 303012A, Exp Sep 2014
- NDC 0597-0075-41, 30 count blister card, Lots 303012B, 303125A, 303253A (Exp Oct 2014), 303895A, 304282A (Exp Nov 2014), 304510A (Exp Dec 2014)
The hazard
The hazard is a defective delivery system due to interaction of the drug product powder with the lubricant on the interior of the capsule shell, according to the FDA. This defect creates a potential for dose delivery out of specification.
Context
GovInfoNow's records show Boehringer Ingelheim Roxane Inc has 12 other recalls on record since 2012-11-05. Other recent recalls of similar products include FUROSEMIDE Tablets USP recall (2015-09-25), Combivent Respimat Recall (2015-07-24), and Acarbose 50mg Tablets recall (2015-04-02).